N9X logo

New Nordic Healthbrands DB:N9X Stock Report

Last Price

€2.05

Market Cap

€13.0m

7D

-5.5%

1Y

n/a

Updated

22 May, 2025

Data

Company Financials

New Nordic Healthbrands AB (publ)

DB:N9X Stock Report

Market Cap: €13.0m

N9X Stock Overview

Develops and markets dietary supplements, herbal remedies, and personal care products in the Nordic countries, rest of Europe, North America, and internationally. More details

N9X fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health3/6
Dividends0/6

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

New Nordic Healthbrands AB (publ) Competitors

Price History & Performance

Summary of share price highs, lows and changes for New Nordic Healthbrands
Historical stock prices
Current Share PriceSEK 2.05
52 Week HighSEK 2.23
52 Week LowSEK 1.15
Beta1.03
1 Month Change64.00%
3 Month Change51.85%
1 Year Changen/a
3 Year Changen/a
5 Year Changen/a
Change since IPO47.48%

Recent News & Updates

Recent updates

Shareholder Returns

N9XDE Personal ProductsDE Market
7D-5.5%3.5%1.7%
1Yn/a-8.0%16.5%

Return vs Industry: Insufficient data to determine how N9X performed against the German Personal Products industry.

Return vs Market: Insufficient data to determine how N9X performed against the German Market.

Price Volatility

Is N9X's price volatile compared to industry and market?
N9X volatility
N9X Average Weekly Movement11.4%
Personal Products Industry Average Movement5.3%
Market Average Movement6.5%
10% most volatile stocks in DE Market12.9%
10% least volatile stocks in DE Market3.1%

Stable Share Price: N9X's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: N9X's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of German stocks.

About the Company

FoundedEmployeesCEOWebsite
199077Karl Kristian Jensenwww.newnordic.se

New Nordic Healthbrands AB (publ) develops and markets dietary supplements, herbal remedies, and personal care products in the Nordic countries, rest of Europe, North America, and internationally. The company provides vitality tablets, capsules, and gummy products, including vitamins and minerals, fish oil and Omega-3, and magnesium, as well as for body, sleep and relaxation, menopause, and men health; skincare products comprising dietary supplements, facial care, and body care, as well as assortment products; hair care products, such as hair volume products, dietary supplements, shampoos, conditioners, and other hair care products; and weight loss products. The company sells its products through pharmacies, department stores, health stores, and travel retailers, as well as through online stores.

New Nordic Healthbrands AB (publ) Fundamentals Summary

How do New Nordic Healthbrands's earnings and revenue compare to its market cap?
N9X fundamental statistics
Market cap€12.97m
Earnings (TTM)-€152.68k
Revenue (TTM)€51.99m
0.2x
P/S Ratio
-84.9x
P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
N9X income statement (TTM)
RevenueSEK 563.91m
Cost of RevenueSEK 198.85m
Gross ProfitSEK 365.05m
Other ExpensesSEK 366.71m
Earnings-SEK 1.66m

Last Reported Earnings

Mar 31, 2025

Next Earnings Date

Jul 31, 2025

Earnings per share (EPS)-0.27
Gross Margin64.74%
Net Profit Margin-0.29%
Debt/Equity Ratio38.6%

How did N9X perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/22 20:40
End of Day Share Price 2025/05/21 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

New Nordic Healthbrands AB (publ) is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.